Pro-Calcifying Role of Enzymatically Modified LDL (eLDL) in Aortic Valve Sclerosis via Induction of IL-6 and IL-33Annemarie Witz(Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology), Michael Torzewski(Robert Bosch Hospital)BiomoleculesJuly 7, 202310.3390/biom13071091Cited by 6SaveCiteExport RISWatch citationsRelated PapersCombined B, T and NK Cell Deficiency Accelerates Atherosclerosis in BALB/c Mice|PLoS ONE|2016|8T Cell-Specific Overexpression of TGFß1 Fails to Influence Atherosclerosis in ApoE-Deficient Mice|PLoS ONE|2013|6